Kristen Albright, Prokarium CEO
Prokarium raises $30M, pushes new bacteria immunotherapy for bladder cancer to clinic
UK biotech Prokarium has raised $30 million as it heads toward the clinic with a Salmonella immunotherapy for bladder cancer, where …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
